The US Food and Drug Administration on July 12 granted clearance to digital health company Eko for its Eko Murmur Analysis Software (EMAS) for detecting and characterizing heart murmurs in adult and pediatric patients, according to a company statement. EMAS allows the Eko smart stethoscope to differentiate between innocent and structural heart murmurs indicative of valvular heart disease.
Read more at Patient Care Online
Please note: Murmur detection is part of Eko’s SENSORA™ Cardiac Disease Detection Platform. Contact our sales team to learn more.